GILD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $79,112,522.26

Gilead Sciences Insider Trading History Chart

Gilead Sciences Share Price & Price History

^$123.76

+0.30 (1.20%)

As of 06/18/2026 04:00 PM ET

Days: 30 | 90 | 365

Gilead Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/15/2026	Andrew D. Dickinson	CFO	Sell	3,000	$125.40	$376,200.00	171,646
6/15/2026	Johanna Mercier	Insider	Sell	3,000	$123.92	$371,760.00	124,234
6/1/2026	Daniel Patrick O'Day	CEO	Sell	15,000	$131.46	$1,971,900.00	617,567
5/15/2026	Andrew D. Dickinson	CFO	Sell	3,000	$132.27	$396,810.00	173,191
5/15/2026	Johanna Mercier	Insider	Sell	28,000	$131.29	$3,676,120.00	125,779
4/28/2026	Daniel Patrick O'Day	CEO	Sell	10,000	$129.16	$1,291,600.00	632,567
4/15/2026	Andrew D. Dickinson	CFO	Sell	3,000	$140.96	$422,880.00	176,191
4/15/2026	Johanna Mercier	Insider	Sell	3,000	$140.96	$422,880.00	128,779
3/16/2026	Andrew D. Dickinson	CFO	Sell	3,000	$144.23	$432,690.00	179,191
3/16/2026	Johanna Mercier	Insider	Sell	3,000	$144.23	$432,690.00	131,779
2/27/2026	Daniel Patrick O'Day	CEO	Sell	10,000	$144.79	$1,447,900.00	642,308
2/17/2026	Andrew D. Dickinson	CFO	Sell	3,000	$154.43	$463,290.00	167,779
2/17/2026	Johanna Mercier	Insider	Sell	28,000	$154.44	$4,324,320.00	120,288
2/5/2026	Daniel Patrick O'Day	CEO	Sell	115,640	$150.00	$17,346,000.00	613,912
1/28/2026	Daniel Patrick O'Day	CEO	Sell	10,000	$139.89	$1,398,900.00	556,698
1/23/2026	Daniel Patrick O'Day	CEO	Sell	115,640	$135.00	$15,611,400.00	566,698
1/20/2026	Jeffrey Bluestone	Director	Sell	5,000	$123.50	$617,500.00	8,920
1/15/2026	Andrew D. Dickinson	CFO	Sell	3,000	$124.31	$372,930.00	150,503
1/15/2026	Johanna Mercier	Insider	Sell	3,000	$124.31	$372,930.00	103,221
12/29/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$124.83	$1,248,300.00	566,698
12/15/2025	Andrew D. Dickinson	CFO	Sell	3,000	$122.00	$366,000.00	153,503
12/15/2025	Johanna Mercier	Insider	Sell	3,000	$122.00	$366,000.00	106,221
11/28/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$126.54	$1,265,400.00	571,203
11/28/2025	Jeffrey Bluestone	Director	Sell	5,000	$125.08	$625,400.00	8,920
11/28/2025	Kelly A. Kramer	Director	Sell	2,805	$127.10	$356,515.50	1,339
11/26/2025	Kelly A. Kramer	Director	Sell	2,806	$127.11	$356,670.66	1,339
11/17/2025	Andrew D. Dickinson	CFO	Sell	2,500	$125.23	$313,075.00	154,555
11/17/2025	Johanna Mercier	Insider	Sell	28,000	$125.86	$3,524,080.00	107,193
11/12/2025	Deborah H. Telman	EVP	Sell	53,646	$122.85	$6,590,411.10	43,676
10/28/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$119.39	$1,193,900.00	581,203
10/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$118.08	$295,200.00	157,055
10/15/2025	Johanna Mercier	Insider	Sell	3,000	$118.08	$354,240.00	110,193
9/29/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$111.66	$1,116,600.00	591,203
9/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$113.57	$283,925.00	159,555
9/15/2025	Johanna Mercier	Insider	Sell	3,000	$113.57	$340,710.00	113,193
8/28/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$113.63	$1,136,300.00	595,725
8/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$118.53	$296,325.00	160,110
8/15/2025	Johanna Mercier	Insider	Sell	28,000	$118.53	$3,318,840.00	114,168
7/28/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$113.94	$1,139,400.00	605,725
7/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$111.03	$277,575.00	162,610
7/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$111.03	$277,575.00	162,610
7/15/2025	Johanna Mercier	Insider	Sell	3,000	$111.03	$333,090.00	117,168
7/15/2025	Johanna Mercier	Insider	Sell	3,000	$111.03	$333,090.00	117,168
7/14/2025	Jeffrey Bluestone	Director	Sell	5,000	$109.74	$548,700.00	8,920
6/30/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$110.45	$1,104,500.00	615,725
6/16/2025	Andrew D. Dickinson	CFO	Sell	2,500	$110.17	$275,425.00	165,110
6/16/2025	Johanna Mercier	Insider	Sell	3,000	$110.17	$330,510.00	120,168
5/30/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$110.42	$1,104,200.00	620,268
5/22/2025	Johanna Mercier	Insider	Sell	28,000	$107.52	$3,010,560.00	121,152
5/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$99.82	$249,550.00	165,674
4/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$106.40	$266,000.00	168,174
3/10/2025	Andrew D. Dickinson	CFO	Sell	17,929	$118.17	$2,118,669.93	169,061
2/18/2025	Andrew D. Dickinson	CFO	Sell	2,500	$104.09	$260,225.00	169,061
2/12/2025	Andrew D. Dickinson	CFO	Sell	137,676	$102.22	$14,073,240.72	171,223
1/31/2025	Andrew D. Dickinson	CFO	Sell	142,180	$97.22	$13,822,739.60	129,873
1/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$91.35	$228,375.00	129,873
12/16/2024	Andrew D. Dickinson	CFO	Sell	8,500	$91.96	$781,660.00	132,373
11/29/2024	Andrew D. Dickinson	CFO	Sell	248,645	$92.76	$23,064,310.20	138,919
11/27/2024	Merdad Parsey	Insider	Sell	164,211	$91.92	$15,094,275.12	80,801
11/26/2024	Jeffrey Bluestone	Director	Sell	6,788	$91.39	$620,355.32	8,920
11/6/2024	Merdad Parsey	Insider	Sell	25,590	$91.50	$2,341,485.00	99,599
10/1/2024	Merdad Parsey	Insider	Sell	2,000	$83.83	$167,660.00	100,189
9/12/2024	Johanna Mercier	Insider	Sell	29,357	$83.78	$2,459,529.46	78,127
8/13/2024	Johanna Mercier	Insider	Sell	5,490	$73.98	$406,150.20	114,979
7/1/2024	Merdad Parsey	Insider	Sell	2,000	$68.63	$137,260.00	96,380
4/1/2024	Merdad Parsey	Insider	Sell	2,000	$72.96	$145,920.00	96,304
2/28/2024	Merdad Parsey	Insider	Sell	2,000	$73.18	$146,360.00	100,936
1/16/2024	Andrew D. Dickinson	CFO	Sell	5,000	$85.78	$428,900.00	101,534
1/9/2024	Johanna Mercier	Insider	Sell	8,242	$85.23	$702,465.66	82,729
10/17/2023	Andrew D. Dickinson	CFO	Sell	5,000	$80.00	$400,000.00	104,003
9/12/2023	Merdad Parsey	Insider	Sell	1,501	$76.99	$115,561.99	70,130
7/20/2023	Andrew D. Dickinson	CFO	Sell	5,000	$80.00	$400,000.00	107,587

SEC Filings (Institutional Ownership Changes) for Gilead Sciences (NASDAQ:GILD)

83.67% of Gilead Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Gilead Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/18/2026	Western Wealth Management LLC	7,949	$1.11M	0.0%	+104.8%	0.001%
6/18/2026	Pacer Advisors Inc.	2,945,242	$410.48M	0.6%	-12.9%	0.237%
6/15/2026	Lombard Odier Asset Management Europe Ltd	12,396	$1.73M	0.0%	-38.0%	0.001%
6/10/2026	FAS Wealth Partners Inc.	1,840	$0.26M	0.0%	N/A	0.000%
6/9/2026	Rathbones Group PLC	2,835	$0.40M	0.0%	-4.4%	0.000%
6/8/2026	First National Bank of Mount Dora Trust Investment Services	1,949	$0.27M	0.1%	-41.1%	0.000%
6/8/2026	Pine Valley Investments Ltd Liability Co	2,427	$0.34M	0.0%	+12.1%	0.000%
6/3/2026	Parallel Advisors LLC	75,984	$10.59M	0.2%	-3.2%	0.006%
6/3/2026	NewEdge Advisors LLC	392,435	$54.69M	0.2%	+144.2%	0.032%
6/1/2026	First Nebraska Trust Co	3,802	$0.53M	0.0%	N/A	0.000%
6/1/2026	Concorde Asset Management LLC	1,692	$0.24M	0.1%	-11.9%	0.000%
6/1/2026	Keel Point LLC	6,604	$0.92M	0.1%	-11.6%	0.001%
5/29/2026	Asset Dedication LLC	12,515	$1.74M	0.1%	-6.8%	0.001%
5/28/2026	Avidity Partners Management LP	20,000	$2.79M	0.6%	N/A	0.002%
5/27/2026	Allen Capital Group LLC	2,400	$0.33M	0.0%	+4.9%	0.000%
5/26/2026	Glenmede Trust Co. NA	221,975	$30.94M	0.2%	-11.0%	0.018%
5/26/2026	Axiom Investment Management LLC	4,858	$0.68M	0.5%	N/A	0.000%
5/22/2026	Groupama Asset Managment	37,990	$5.30M	0.1%	-25.8%	0.003%
5/22/2026	Verus Capital Partners LLC	2,882	$0.40M	0.0%	-20.0%	0.000%
5/21/2026	J. Derek Lewis & Associates Inc.	3,020	$0.42M	0.1%	+7.1%	0.000%
5/21/2026	Groupe la Francaise	37,915	$5.28M	0.1%	+12.2%	0.003%
5/20/2026	Norris Financial Group LLC	16,583	$2.31M	0.8%	N/A	0.001%
5/19/2026	Western Wealth Management LLC	7,949	$1.11M	0.0%	+104.8%	0.001%
5/19/2026	Winnow Wealth LLC	8,611	$1.20M	0.9%	-5.4%	0.001%
5/19/2026	Sonoma Allocations LLC	3,174	$0.44M	0.2%	-17.2%	0.000%
5/19/2026	Paragon Private Wealth Management LLC	1,965	$0.27M	0.1%	+4.5%	0.000%
5/19/2026	Royal Fund Management LLC	1,876	$0.26M	0.0%	-79.6%	0.000%
5/19/2026	Ariadne Wealth Management LP	5,675	$0.79M	0.4%	-15.0%	0.000%
5/19/2026	Bank of America Corp DE	19,978,936	$2.78B	0.2%	-13.6%	1.609%
5/19/2026	Hamilton Wealth LLC	119,118	$16.60M	1.2%	+210.5%	0.010%
5/19/2026	Twin Lakes Capital Management LLC	58,102	$8.10M	3.1%	-1.1%	0.005%
5/19/2026	Kentucky Retirement Systems	126,596	$17.64M	0.6%	+61.9%	0.010%
5/19/2026	Janus Henderson Group PLC	1,972,639	$274.92M	0.1%	+5.9%	0.159%
5/19/2026	Centaurus Financial Inc.	6,319	$0.88M	0.0%	+19.3%	0.001%
5/19/2026	Oddo BHF Asset Management Sas	141,289	$19.69M	0.8%	+8.9%	0.011%
5/19/2026	Bull Harbor Capital LLC	2,135	$0.30M	0.1%	N/A	0.000%
5/19/2026	Ashton Thomas Securities LLC	2,202	$0.31M	0.0%	+7.5%	0.000%
5/19/2026	Arkadios Wealth Advisors	103,457	$14.42M	0.2%	+121.9%	0.008%
5/19/2026	South Dakota Investment Council	24,446	$3.41M	0.1%	-9.9%	0.002%
5/18/2026	ADAR1 Capital Management LLC	6,351	$0.89M	0.1%	-4.7%	0.001%
5/18/2026	Sunbelt Securities Inc.	12,141	$1.69M	0.1%	+5.5%	0.001%
5/18/2026	Amundi	10,539,111	$1.47B	0.4%	+10.7%	0.849%
5/18/2026	Gould Capital LLC	12,160	$1.70M	1.0%	-9.2%	0.001%
5/18/2026	EverSource Wealth Advisors LLC	6,777	$0.94M	0.0%	+14.6%	0.001%
5/18/2026	California State Teachers Retirement System	1,914,292	$266.80M	0.3%	-2.1%	0.154%
5/18/2026	Elite Wealth Management Inc.	10,468	$1.46M	0.5%	+3.6%	0.001%
5/18/2026	Empowered Funds LLC	195,463	$27.24M	0.2%	+41.8%	0.016%
5/18/2026	Evercore Wealth Management LLC	10,713	$1.49M	0.0%	-2.4%	0.001%
5/16/2026	The Manufacturers Life Insurance Company	1,242,331	$173.14M	0.1%	-29.4%	0.100%
5/16/2026	KCM Investment Advisors LLC	21,924	$3.06M	0.1%	+69.8%	0.002%
5/16/2026	Glen Eagle Advisors LLC	563	$78K	0.0%	+20.0%	0.000%
5/16/2026	Quantinno Capital Management LP	661,397	$92.18M	0.2%	+21.6%	0.053%
5/16/2026	Lazard Asset Management LLC	299,734	$41.77M	0.1%	-0.4%	0.024%
5/16/2026	Castleark Management LLC	342,150	$47.69M	1.6%	+23.4%	0.028%
5/16/2026	Family Manage LLC	29,557	$4.12M	0.5%	-47.7%	0.002%
5/16/2026	Orbimed Advisors LLC	59,600	$8.31M	0.2%	N/A	0.005%
5/15/2026	Intelligence Driven Advisers LLC	4,562	$0.64M	0.1%	+57.5%	0.000%
5/15/2026	Gateway Wealth Partners LLC	10,298	$1.44M	0.1%	+152.8%	0.001%
5/15/2026	Quadcap Wealth Management LLC	4,918	$0.69M	0.1%	-2.8%	0.000%
5/15/2026	Cypress Capital Group	48,427	$6.75M	0.7%	-0.3%	0.004%
5/15/2026	OMERS ADMINISTRATION Corp	1,163,062	$162.10M	1.0%	+1,456.8%	0.094%
5/15/2026	44 Wealth Management LLC	1,978	$0.28M	0.1%	-32.6%	0.000%
5/15/2026	Van Diest Capital LLC	2,052	$0.29M	0.2%	N/A	0.000%
5/15/2026	Bradley Foster & Sargent Inc. CT	39,053	$5.44M	0.1%	-3.8%	0.003%
5/15/2026	Lombard Odier Asset Management Switzerland SA	57,445	$8.01M	0.3%	+7.1%	0.005%
5/15/2026	Lombard Odier Asset Management Europe Ltd	12,396	$1.73M	0.1%	-38.0%	0.001%
5/15/2026	Aristotle Atlantic Partners LLC	4,000	$0.56M	0.0%	N/A	0.000%
5/15/2026	Waverly Advisors LLC	33,822	$4.71M	0.0%	+27.8%	0.003%
5/15/2026	Wealth Alliance LLC	2,649	$0.37M	0.0%	-62.4%	0.000%
5/15/2026	Epoch Investment Partners Inc.	549,365	$76.57M	0.5%	-8.0%	0.044%
5/15/2026	Entropy Technologies LP	74,691	$10.41M	0.5%	N/A	0.006%
5/15/2026	Sustainable Insight Capital Management LLC	2,538	$0.35M	0.1%	N/A	0.000%
5/15/2026	Empirical Finance LLC	42,134	$5.87M	0.3%	-0.2%	0.003%
5/15/2026	Bridgewater Advisors Inc.	5,999	$0.80M	0.0%	-2.6%	0.000%
5/14/2026	Healthcare of Ontario Pension Plan Trust Fund	1,299,000	$181.04M	0.3%	-26.3%	0.105%
5/14/2026	Dai ichi Life Insurance Company Ltd	195,288	$27.22M	0.8%	-6.6%	0.016%
5/14/2026	Renaissance Technologies LLC	2,152,528	$300M	0.5%	-22.8%	0.173%
5/14/2026	Gabelli Funds LLC	7,300	$1.02M	0.0%	+15.9%	0.001%
5/14/2026	Hilltop Holdings Inc.	20,872	$2.91M	0.3%	-28.1%	0.002%
5/14/2026	Morningstar Investment Management LLC	3,226	$0.45M	0.0%	-17.1%	0.000%
5/14/2026	GC Wealth Management RIA LLC	3,246	$0.45M	0.0%	-29.8%	0.000%
5/14/2026	Public Employees Retirement System of Ohio	565,802	$78.86M	0.3%	-3.0%	0.046%
5/14/2026	Compound Planning Inc.	39,125	$5.45M	0.2%	+8.2%	0.003%
5/14/2026	Klingman & Associates LLC	2,645	$0.37M	0.0%	+4.7%	0.000%
5/14/2026	Modern Wealth Management LLC	10,592	$1.49M	0.0%	+12.4%	0.001%
5/14/2026	Keebeck Wealth Management	4,185	$0.58M	0.1%	+27.1%	0.000%
5/14/2026	Orleans Capital Management Corp LA	10,852	$1.51M	1.0%	+2.3%	0.001%
5/14/2026	Oak Associates Ltd. OH	81,776	$11.40M	0.8%	-5.8%	0.007%
5/14/2026	Caxton Associates LLP	1,441	$0.20M	0.0%	-99.7%	0.000%
5/14/2026	Inceptionr LLC	4,291	$0.60M	0.1%	N/A	0.000%
5/14/2026	Liberty One Investment Management LLC	50,865	$7.09M	0.7%	+4.2%	0.004%
5/14/2026	Bowen Hanes & Co. Inc.	1,510	$0.21M	0.0%	-50.0%	0.000%
5/14/2026	Bank of Nova Scotia	723,376	$100.82M	0.2%	-41.1%	0.058%
5/14/2026	Gibbs Wealth Management	6,629	$0.92M	0.1%	+57.5%	0.001%
5/14/2026	Sei Investments Co.	1,158,099	$161.41M	0.1%	+6.0%	0.093%
5/14/2026	Davis R M Inc.	2,174	$0.30M	0.0%	+26.1%	0.000%
5/14/2026	Lido Advisors LLC	120,592	$16.81M	0.1%	+0.4%	0.010%
5/14/2026	State of Wyoming	556	$77K	0.0%	-83.4%	0.000%
5/13/2026	Cetera Investment Advisers	404,797	$56.42M	0.1%	-0.7%	0.033%
5/13/2026	Wealthspire Retirement LLC	15,981	$2.23M	0.1%	+0.7%	0.001%

Data available starting January 2016

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Today's Range

Now: $123.76

$122.43

$126.39

50 Day Range

MA: $131.66

$121.48

$142.09

52 Week Range

Now: $123.76

$104.46

$157.29

Volume

14,254,717 shs

Average Volume

8,542,013 shs

Market Capitalization

$153.66 billion

P/E Ratio

16.86

Dividend Yield

2.65%

Beta

0.31

Who are the company insiders with the largest holdings of Gilead Sciences?: Gilead Sciences' top insider investors include:
John Martin (CEO)
John C Martin (Chairman)
John C Martin (Insider)
John C Martin (CEO)
John C Martin (Director)
Norbert Bischofberger (EVP)
John F Milligan (CEO)
John F Milligan (Insider)
John F Milligan (COO)
Daniel Patrick O'day (CEO)
Learn More about top insider investors at Gilead Sciences.
Who are the major institutional investors of Gilead Sciences?: Gilead Sciences' top institutional investors include:
Bank of America Corp DE — 1.61%
Amundi — 0.85%
Dimensional Fund Advisors LP — 0.62%
Swiss National Bank — 0.29%
California Public Employees Retirement System — 0.29%
First Trust Advisors LP — 0.25%
Learn More about top institutional investors of Gilead Sciences stock.
Which institutional investors are selling Gilead Sciences stock?: During the last quarter, GILD stock was sold by these institutional investors:
Bank of America Corp DE
Dimensional Fund Advisors LP
Renaissance Technologies LLC
KBC Group NV
Caxton Associates LLP
The Manufacturers Life Insurance Company
Bank of Nova Scotia
Healthcare of Ontario Pension Plan Trust Fund
In the last year, company insiders that have sold Gilead Sciences company stock include:
Daniel Patrick O'day (CEO)
Andrew D Dickinson (CFO)
Johanna Mercier (Insider)
Deborah H Telman (EVP)
Jeffrey Bluestone (Director)
Kelly A Kramer (Director)
Learn More investors selling Gilead Sciences stock.
Which institutional investors are buying Gilead Sciences stock?: Within the previous quarter, GILD stock was bought by institutional investors including:
First Trust Advisors LP
SEB Asset Management AB
OMERS ADMINISTRATION Corp
Amundi
Jennison Associates LLC
OP Asset Management Ltd
Assenagon Asset Management S.A.
Swiss National Bank